Michael Hoelscher

Michael Hoelscher is a Professor at Ludwig Maximilian University of Munich, serving as Tuberculosis Coordinator and Location spokesperson at LMU Hospital Munich. His research focuses on HIV-tuberculosis co-infections and drug efficacy evaluation.

He leads the International Clinical Trials Group, facilitating clinical research in disease-endemic regions like Africa, and oversees the MycoDrugs and Trials platform for preclinical testing against mycobacteria. The platform utilizes in vitro systems and an aerosol inhalation mouse model for tuberculosis drug development.